Clinical trials recruiting for Metastatic Prostate Carcinoma

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• Access to Genetic Testing in Underserved Patients With Cancer
  NCT06422455 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• Bright White Light Therapy in Reducing Cancer-Related Fatigue and Depression in Advanced Prostate Cancer Patients Undergoing Treatment With ADT Combination Therapy
  NCT05869682 · Phase: Phase 2 · Ages: 60 Years and older · Sex: Male · 1 location
• Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial
  NCT04693377 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Debunking the Frailty-sarcopenIa-ADT Axis in mEtastatic Prostate canceR With multiComponent Exercise: The FIERCE Trial
  NCT06040125 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · 3 locations
• Evaluating In Home Cancer Therapy Versus In Clinic Cancer Therapy in Black Men With Locally Advanced, Biochemically Recurrent and Metastatic Prostate Cancer
  NCT07073794 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Extending Prostate Genetic Awareness, Navigation, and Delivery: The EXPAND Network
  NCT05627219 · Phase: Not specified · Ages: 18 Years and older · Sex: Male · 1 location
• FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer, The PRTY Trial
  NCT06244004 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 6 locations
• Image-Guided Biopsies to Identify Mechanisms of Resistance in Patients With Metastatic Castration Resistant Prostate Cancer Treated With 177Lu-PSMA Radioligand Therapy
  NCT05398302 · Phase: Phase 1 · Ages: No age limits stated · Sex: Male · 1 location
• Immunological Effects of Vitamin D Replacement Among Black/African American Prostate Cancer Patients
  NCT05045066 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: Male · 2 locations
• Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer
  NCT04489719 · Phase: Not specified · Ages: 18 Years and older · Sex: Male · 4 locations
• PSCA-Targeting CAR-T Cells Plus or Minus Radiation for the Treatment of Patients With PSCA+ Metastatic Castration-Resistant Prostate Cancer
  NCT05805371 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · 1 location
• Peer Navigation for the Support of Metastatic Prostate Cancer Patients Undergoing Genetic Evaluation
  NCT05487846 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · 1 location
• Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
  NCT04423211 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 341 locations

Related conditions

Trials recruiting for Metastatic Prostate Carcinoma often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Metastatic Prostate Carcinoma trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.